Aarti Pharmalabs Q3 Results
- BSE: 543748
- NSE: AARTIPHARM
- ISIN: INE0LRU01027
- Sector: Biotechnology & Drugs
BSE
689.60
7.85 (1.15%)
7.85 (1.15%)Volume5.27 K
Updated: Fri 10 Apr, 2026 | 15:28:20
NSE
689.058.10 (1.19%)
8.10 (1.19%)Volume1.08 L
Updated: Fri 10 Apr, 2026 | 15:40:13
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
- Total Income₹432.27 Cr.(-19.62%)
- Operating Profit₹70.90 Cr.(-32.85%)
- Profit After Tax₹47.96 Cr.(-35.18%)
- Operating Margin16.40%(-16.46%)
Note: Comparison is on YoY basis
Quarterly - Aarti Pharmalabs Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 361.38 | 385.24 | -1.90% | 371.78 | -16.39% |
| Depreciation/ Amortization | 28.62 | 20.88 | 15.54% | 18.77 | 24.22% |
| Operating Income | 70.90 | 72.79 | 41.93% | 76.91 | -32.85% |
| Net Income | 47.96 | 54.62 | 71.74% | 52.76 | -35.18% |
| Other Operating Expenses Total | 113.93 | 91.05 | 25.99% | 72.42 | 23.53% |
| Net Income Before Taxes | 62.87 | 71.77 | 62.48% | 73.82 | -37.52% |
| Total Revenue | 432.27 | 458.03 | 3.33% | 448.69 | -19.62% |
| Selling/ General/ Admin Expenses Total | 43.38 | 37.73 | -0.08% | 36.16 | 4.20% |
| Diluted Normalized EPS | 5.53 | 6.02 | 79.65% | 5.82 | -32.19% |